Jacqueline Palace

• Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.

  Journal article

  Sisay S. et al, (2017), J Neuroimmunol, 306, 40 - 45

• Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.

  Journal article

  Jurynczyk M. et al, (2017), Brain, 140, 617 - 627

• Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

  Journal article

  Juryńczyk M. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 132 - 136

• Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

  Journal article

  Tackley G. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 165 - 169

• Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

  Journal article

  Geraldes R. et al, (2016), Brain Pathol

• Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status.

  Journal article

  Kong Y. et al, (2016), J Neurol Sci, 368, 84 - 88

• Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

  Journal article

  Waters P. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 1005 - 1015

• Muscle magnetic resonance imaging in congenital myasthenic syndromes.

  Journal article

  Finlayson S. et al, (2016), Muscle Nerve, 54, 211 - 219

• Clinical features of the myasthenic syndrome arising from mutations in GMPPB.

  Journal article

  Rodríguez Cruz PM. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 802 - 809

• Chronic pain disrupts the reward circuitry in multiple sclerosis.

  Journal article

  Seixas D. et al, (2016), Eur J Neurosci, 44, 1928 - 1934

• Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.

  Journal article

  Rodríguez Cruz PM. et al, (2016), JAMA Neurol, 73, 954 - 960

• The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

  Journal article

  Vermersch P. et al, (2016), Mult Scler, 22, 18 - 33

• Atypical inflammatory demyelinating syndromes of the CNS.

  Journal article

  Hardy TA. et al, (2016), Lancet Neurol, 15, 967 - 981

• International consensus guidance for management of myasthenia gravis: Executive summary.

  Journal article

  Sanders DB. et al, (2016), Neurology, 87, 419 - 425

• Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.

  Journal article

  Tackley G. et al, (2016), Mult Scler Relat Disord, 7, 21 - 25

• Myasthenia gravis: a clinical-immunological update.

  Journal article

  Binks S. et al, (2016), J Neurol, 263, 826 - 834

• Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.

  Journal article

  Huda S. et al, (2016), J Neurol Sci, 362, 66 - 68

• MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

  Journal article

  Filippi M. et al, (2016), Lancet Neurol, 15, 292 - 303

• Fibrinogen deposition in the multiple sclerosis motor cortex

  Conference paper

  Yates RL. et al, (2016), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 42, 33 - 33

• Systemic Vascular Disease Burden in Multiple Sclerosis: a post mortem case - control study

  Conference paper

  Geraldes R. et al, (2016), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 42, 24 - 25

• Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome.

  Journal article

  Allen NM. et al, (2016), Neurology, 86, 692 - 694

• The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.

  Journal article

  Duddy M. and Palace J., (2016), Pract Neurol, 16, 4 - 6

• Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

  Journal article

  Piccolo L. et al, (2016), J Neurol, 263, 370 - 379

• Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.

  Journal article

  McGuigan C. et al, (2016), J Neurol Neurosurg Psychiatry, 87, 117 - 125

• Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

  Journal article

  Nour MM. et al, (2016), Neurology, 86, 79 - 87

• Therapeutic options in neuromyelitis optica spectrum disorders.

  Journal article

  Kitley J. and Palace J., (2016), Expert Rev Neurother, 16, 319 - 329

• Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment.

  Journal article

  Pittock SJ. and Palace J., (2016), Handb Clin Neurol, 133, 165 - 183

• Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.

  Journal article

  Juryńczyk M. et al, (2016), J Neurol, 263, 140 - 149

• Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.

  Journal article

  Logan CV. et al, (2015), Am J Hum Genet, 97, 878 - 885

• Antibodies to aquaporin-1 are not present in neuromyelitis optica.

  Journal article

  Schanda K. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

  Journal article

  McKee JB. et al, (2015), BMJ Open, 5

• Structural imaging of the cervical spinal cord with suppressed CSF signal using DANTE pulse trains.

  Journal article

  Li L. et al, (2015), Magn Reson Med, 74, 971 - 977

• A novel mutation in a patient with a DOK7 congenital myasthenic syndrome

  Conference paper

  Willis T. et al, (2015), NEUROMUSCULAR DISORDERS, 25, S210 - S210

• Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.

  Journal article

  Rodríguez Cruz PM. et al, (2015), Neurology, 85, 1043 - 1047

• Relapsing central nervous system demyelination in children with myelin oligodendrocyte glycoprotein (MOG) antibodies

  Conference paper

  Hacohen Y. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 88 - 89

• A randomised, double-blind, placebo-controlled, multi-centre trial to evaluate the safety and efficacy of eculizumab in patients with relapsing neuromyelitis optica: the PREVENT study

  Conference paper

  Wingerchuk DM. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 759 - 759

• Neuromyelitis optica spectrum disorders and polyautoimmunity

  Conference paper

  Correia AS. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 655 - 656

• The influence of HLA-DRB1*15 on motor cortical neurodegeneration in multiple sclerosis

  Conference paper

  Yates RL. et al, (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 424 - 424

• Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.

  Journal article

  Belaya K. et al, (2015), Brain, 138, 2493 - 2504

• Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.

  Journal article

  Murchison A. et al, (2015), J Neurol Sci, 355, 49 - 53

• Update on biomarkers in neuromyelitis optica.

  Journal article

  Melamed E. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.

  Journal article

  Kitley J. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

  Journal article

  Kremer S. et al, (2015), JAMA Neurol, 72, 815 - 822

• Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

  Journal article

  Rodríguez Cruz PM. et al, (2015), JAMA Neurol, 72, 642 - 649

• MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

  Journal article

  Waters P. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• Demographic and clinical features of neuromyelitis optica: A review.

  Journal article

  Pandit L. et al, (2015), Mult Scler, 21, 845 - 853

• Cardiac safety and tolerability of fingolimod in relapsing MS patients from the FIRST study who transitioned into the LONGTERMS study

  Conference paper

  Palace JA. et al, (2015), EUROPEAN JOURNAL OF NEUROLOGY, 22, 254 - 254

• Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).

  Journal article

  Absoud M. et al, (2015), BMJ Open, 5

• MRI in Leber's hereditary optic neuropathy:The relationship to multiple sclerosis

  Journal article

  Matthews L. et al, (2015), Journal of Neurology, Neurosurgery and Psychiatry, 86, 537 - 542

• MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.

  Journal article

  Matthews L. et al, (2015), J Neurol Neurosurg Psychiatry, 86, 537 - 542

• Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

  Journal article

  Bennett JL. et al, (2015), Mult Scler, 21, 678 - 688

• Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.

  Journal article

  Palace J. et al, (2015), Lancet Neurol, 14, 497 - 505

• Placebo studies should not be undertaken in NMO--Yes.

  Journal article

  Palace J., (2015), Mult Scler, 21, 689 - 691

• What is Seronegative NMO?

  Journal article

  Palace J., (2015), MULTIPLE SCLEROSIS JOURNAL, 21, 801 - 802

• Challenges and opportunities in designing clinical trials for neuromyelitis optica.

  Journal article

  Weinshenker BG. et al, (2015), Neurology, 84, 1805 - 1815

• Paediatric neuromyelitis optica: Clinical, MRI of the brain and prognostic features

  Journal article

  Absoud M. et al, (2015), Journal of Neurology, Neurosurgery and Psychiatry, 86, 470 - 472

• The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.

  Journal article

  Yates RL. et al, (2015), Neuropathol Appl Neurobiol, 41, 371 - 384

• Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.

  Journal article

  Absoud M. et al, (2015), J Neurol Neurosurg Psychiatry, 86, 470 - 472

• Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.

  Journal article

  Hacohen Y. et al, (2015), Neurol Neuroimmunol Neuroinflamm, 2

• The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis

  Journal article

  Yates RL. et al, (2015), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 41, 371 - 384

• Multiple sclerosis in Japan appears to be a milder disease compared to the UK

  Journal article

  Piccolo L. et al, (2015), Journal of Neurology, 262, 831 - 836

• MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

  Journal article

  Kim HJ. et al, (2015), Neurology, 84, 1165 - 1173

• Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: A clinical cohort study with natural history comparator

  Journal article

  Palace J. et al, (2015), The Lancet Neurology, 14, 497 - 505

• Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.

  Journal article

  Juryńczyk M. et al, (2015), J Neurol Neurosurg Psychiatry, 86, 20 - 25

• Multiple sclerosis in Japan appears to be a milder disease compared to the UK.

  Journal article

  Piccolo L. et al, (2015), J Neurol, 262, 831 - 836

• Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.

  Journal article

  Matthews L. et al, (2015), PLoS One, 10

• Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease

  Journal article

  Murchison A. et al, (2015), Journal of the Neurological Sciences, 355, 49 - 53

• Neuroimmunology: Towards more-accurate diagnosis in neuromyelitis optica

  Journal article

  Fujihara K. and Palace J., (2014), Nature Reviews Neurology, 10, 679 - 681

• Congenital myopathies with secondary neuromuscular transmission defects; A case report and review of the literature

  Journal article

  Rodríguez Cruz PM. et al, (2014), Neuromuscular Disorders, 24

• Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.

  Journal article

  Rodríguez Cruz PM. et al, (2014), Neuromuscul Disord, 24, 1103 - 1110

• Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.

  Journal article

  Fujihara K. and Palace J., (2014), Nat Rev Neurol, 10, 679 - 681

• Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation

  Journal article

  Themistocleous AC. et al, (2014), Journal of Neurology, 261, 2230 - 2233

• Opportunistic infections of the retina in patients with aquaporin-4 antibody disease.

  Journal article

  George JS. et al, (2014), JAMA Neurol, 71, 1429 - 1432

• Inherited disorders of the neuromuscular junction: an update.

  Journal article

  Rodríguez Cruz PM. et al, (2014), J Neurol, 261, 2234 - 2243

• Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation.

  Journal article

  Themistocleous AC. et al, (2014), J Neurol, 261, 2230 - 2233

• A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.

  Journal article

  Dickens AM. et al, (2014), Neurology, 83, 1492 - 1499

• Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders

  Conference paper

  Cheng F. et al, (2014), JOURNAL OF NEUROIMMUNOLOGY, 275, 76 - 77

• Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres

  Conference paper

  Waters P. et al, (2014), JOURNAL OF NEUROIMMUNOLOGY, 275, 15 - 15

• Unaltered frequency and functionality of CD56bright and CD56dim natural killer cells in untreated relapsing-remitting multiple sclerosis patients

  Conference paper

  Sisay S. et al, (2014), JOURNAL OF NEUROIMMUNOLOGY, 275, 46 - 46

• Congenital myasthenic syndromes and the neuromuscular junction

  Journal article

  Cruz PMR. et al, (2014), Current Opinion in Neurology, 27, 566 - 575

• Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.

  Journal article

  Elsone L. et al, (2014), Mult Scler, 20, 1533 - 1540

• Congenital myasthenic syndromes and the neuromuscular junction.

  Journal article

  Rodríguez Cruz PM. et al, (2014), Curr Opin Neurol, 27, 566 - 575

• PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

  Conference paper

  Nour M. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM

  Conference paper

  McKee J. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• THE UK MS RISK-SHARING SCHEME: RESULTS FOR YEARS 4 AND 6

  Conference paper

  Duddy M. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85

• Treatments in NMO: current algorithms, future therapies and trial designs

  Conference paper

  Palace J., (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 6 - 7

• Neuromyelitis optica: annual relapse rates off and on immunosuppression and the relationship to attack type and ethnicity

  Conference paper

  Tackley G. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 352 - 353

• Multimodal clinical trial paradigm to assess neuroprotection in optic neuritis: baseline data

  Conference paper

  Mckee JB. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 361 - 361

• MRI study of Leber's hereditary optic neuropathy and MS suggests common lesion pathology and an 83% risk of MS-like lesions in females with LHON

  Conference paper

  Matthews L. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 170 - 171

• Inflammation does not cause chronic global neurodegeneration in NMO? A longitudinal multimodel quantitative MRI study comparing NMO and MS

  Conference paper

  Matthews L. et al, (2014), MULTIPLE SCLEROSIS JOURNAL, 20, 282 - 282

• Magnetic resonance imaging in neuromyelitis optica.

  Journal article

  Tackley G. et al, (2014), Mult Scler, 20, 1153 - 1164

• Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.

  Journal article

  Kitley J. et al, (2014), JAMA Neurol, 71

• Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.

  Journal article

  Collongues N. et al, (2014), Mult Scler, 20, 1086 - 1094

• Modifying disability in progressive multiple sclerosis.

  Journal article

  Palace J. and Robertson N., (2014), Lancet, 383, 2189 - 2191

• Inherited myasthenic syndromes

  Chapter

  Palace J. and Finlayson S., (2014), Oxford Textbook of Neuromuscular Disorders, 175 - 183

• Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group.

  Journal article

  Norwood F. et al, (2014), J Neurol Neurosurg Psychiatry, 85, 538 - 543

• Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.

  Journal article

  Kitley J. et al, (2014), J Neurol Neurosurg Psychiatry, 85, 589 - 590

• The role of imaging in diagnosing neuromyelitis optica spectrum disorder.

  Journal article

  Matthews LA. and Palace JA., (2014), Mult Scler Relat Disord, 3, 284 - 293

• Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials

  Journal article

  Kitley J. et al, (2014), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85, 589 - U118

• The impact of neuromyelitis optica spectrum disorder on pregnancy outcome

  Conference paper

  Nour MM. et al, (2014), EUROPEAN JOURNAL OF NEUROLOGY, 21, 758 - 758

• The impact of neuromyelitis optica spectrum disorder on pregnancy outcome

  Conference paper

  Nour MM. et al, (2014), JOURNAL OF NEUROLOGY, 261, S487 - S487

• Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.

  Journal article

  Kitley J. et al, (2014), J Neurol Sci, 339, 223 - 225

• Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab

  Journal article

  Kitley J. et al, (2014), Journal of the Neurological Sciences, 339, 223 - 225

• Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

  Journal article

  Wallner-Blazek M. et al, (2014), J Neurol, 261, 848 - 849

• Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

  Journal article

  Gold R. et al, (2014), J Neurol, 261

• UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model (BMJ Open (2014) 4, (e004073))

  Journal article

  Palace J. et al, (2014), BMJ Open, 4

• Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

  Journal article

  Kitley J. et al, (2014), JAMA Neurol, 71, 276 - 283

• Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

  Journal article

  Mealy MA. et al, (2014), JAMA Neurol, 71, 324 - 330

• Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study

  Journal article

  Kitley J. et al, (2014), JAMA NEUROLOGY, 71, 276 - 283

• Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic

  Conference paper

  Healy EG. et al, (2014), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 40, 42 - 42

• Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

  Journal article

  Gold R. et al, (2014), J Neurol, 261, 267 - 276

• UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.

  Journal article

  Palace J. et al, (2014), BMJ Open, 4

• The role of imaging in diagnosing neuromyelitis optica spectrum disorder

  Journal article

  Matthews LA. and Palace JA., (2014), Multiple Sclerosis and Related Disorders, 3, 284 - 293

• Myasthenia in pregnancy: Best practice guidelines from a UK multispecialty working group

  Journal article

  Norwood F. et al, (2014), Journal of Neurology, Neurosurgery and Psychiatry, 85, 538 - 543

• Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study

  Journal article

  Gold R. et al, (2014), Journal of Neurology, 261, 267 - 276

• Erratum: Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis (Journal of Neurology (2013) 260 (2016-2022) DOI: 10.1007/s00415-013-6918-y)

  Journal article

  Wallner-Blazek M. et al, (2014), Journal of Neurology, 261, 848 - 849

• Erratum: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: A phase 3b, open-label study (Journal of Neurology (2014) 261 (267-276) DOI: 10.1007/s00415-013-7115-8)

  Journal article

  Gold R. et al, (2014), Journal of Neurology, 261

• Modifying disability in progressive multiple sclerosis

  Journal article

  Palace J. and Robertson N., (2014), The Lancet, 383, 2189 - 2191

• A novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations

  Journal article

  Lewis AJM. et al, (2014), Experimental and Clinical Cardiology, 20, 3139 - 3145

• Acute, multifocal neurological symptoms

  Chapter

  Kitley J. et al, (2014), Imaging Acute Neurologic Disease: A Symptom-Based Approach, 209 - 227

• Clinical commentary.

  Journal article

  Palace J., (2014), Mult Scler, 20

• UK multiple sclerosis risksharing scheme: A new natural history dataset and an improved Markov model (BMJ Open (2014) 4, (e004073))

  Journal article

  Palace J. et al, (2014), BMJ Open, 4

• Pain in multiple sclerosis: a systematic review of neuroimaging studies.

  Journal article

  Seixas D. et al, (2014), Neuroimage Clin, 5, 322 - 331

• Partnership and consent in MS treatment choice.

  Journal article

  Palace J., (2013), J Neurol Sci, 335, 5 - 8

• Partnership and consent in MS treatment choice

  Journal article

  Palace J., (2013), Journal of the Neurological Sciences, 335, 5 - 8

• DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

  Journal article

  Klein A. et al, (2013), Neuromuscular Disorders, 23, 883 - 891

• Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

  Journal article

  Kitley J. et al, (2013), JAMA Neurol, 70, 1375 - 1381

• Improving the model for the uk ms disease modifying treatment risk sharing scheme analysis: a new natural history dataset.

  Journal article

  Palace J. et al, (2013), J Neurol Neurosurg Psychiatry, 84

• A decade of data for the uk multiple sclerosis risk-sharing scheme.

  Journal article

  Duddy M. and Palace J., (2013), J Neurol Neurosurg Psychiatry, 84

• DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.

  Journal article

  Klein A. et al, (2013), Neuromuscul Disord, 23, 883 - 891

• Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.

  Journal article

  Finlayson S. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 1119 - 1125

• Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders

  Conference paper

  Kitley J. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 83 - 84

• Improved MRI-derived assessment of grey and white matter volumes by using SIENAX

  Conference paper

  Battaglini M. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 424 - 425

• Microcystic inner nuclear layer pathology in aquaporin-4 antibody-positive patients

  Conference paper

  George J. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 432 - 433

• Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks

  Conference paper

  Murchison AG. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 329 - 329

• Multiple sclerosis patients in Japan appear to have less disability compared to the UK

  Conference paper

  Kumar G. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 341 - 341

• Modelling natural history for the UK multiple sclerosis risk-sharing scheme

  Conference paper

  Palace J. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 339 - 339

• Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom

  Conference paper

  Elsone L. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 446 - 447

• Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom

  Conference paper

  Elsone L. et al, (2013), MULTIPLE SCLEROSIS JOURNAL, 19, 233 - 233

• Brain atrophy and lesion load predict long term disability in multiple sclerosis.

  Journal article

  Popescu V. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 1082 - 1091

• Atypical idiopathic inflammatory demyelinating lesions: Prognostic implications and relation to multiple sclerosis

  Journal article

  Wallner-Blazek M. et al, (2013), Journal of Neurology, 260, 2016 - 2022

• Low Myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica

  Journal article

  Ciccarelli O. et al, (2013), Annals of Neurology, 74, 301 - 305

• Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

  Journal article

  Kitley J. et al, (2013), J Neurol Neurosurg Psychiatry, 84, 918 - 921

• Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica.

  Journal article

  Ciccarelli O. et al, (2013), Ann Neurol, 74, 301 - 305

• Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

  Journal article

  Wallner-Blazek M. et al, (2013), J Neurol, 260, 2016 - 2022

• Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.

  Journal article

  Matthews L. et al, (2013), Neurology, 80, 1330 - 1337

• Congenital myasthenic syndromes: an update.

  Journal article

  Finlayson S. et al, (2013), Pract Neurol, 13, 80 - 91

• Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.

  Journal article

  Cossins J. et al, (2013), Brain, 136, 944 - 956

• ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride

  Journal article

  Arun T. et al, (2013), NEUROLOGY, 80

• Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica

  Journal article

  Kitley J. et al, (2013), NEUROLOGY, 80

• Telephone Assessment of the Expanded Disability Status Scale

  Journal article

  Huda S. and Palace J., (2013), NEUROLOGY, 80

• Characterization of NMO and NMOSD Patients with a Late Onset

  Journal article

  Collongues N. et al, (2013), NEUROLOGY, 80

• Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.

  Journal article

  Finlayson S. et al, (2013), Muscle Nerve, 47, 279 - 282

• Congenital myasthenic syndromes due to mutations in ALG2 and ALG14

  Journal article

  Cossins J. et al, (2013), Brain, 136, 944 - 956

• Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1

  Journal article

  Finlayson S. et al, (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84, 1119 - 1125

• Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies

  Journal article

  Kitley J. et al, (2013), Journal of Neurology, Neurosurgery and Psychiatry, 84, 918 - 921

• Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression.

  Journal article

  Gnanapavan S. et al, (2013), PLoS One, 8

• Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.

  Journal article

  Arun T. et al, (2013), Brain, 136, 106 - 115

• Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride

  Journal article

  Arun T. et al, (2013), Brain, 136, 106 - 115

• Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.

  Journal article

  Belaya K. et al, (2012), Ann N Y Acad Sci, 1275, 29 - 35

• The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.

  Journal article

  Gelineau-Morel R. et al, (2012), Hum Brain Mapp, 33, 2802 - 2814

• Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.

  Journal article

  Jacob A. et al, (2012), Mult Scler, 18, 1801 - 1803

• DOK7 congenital myasthenic syndrome.

  Journal article

  Palace J., (2012), Ann N Y Acad Sci, 1275, 49 - 53

• Neuroplasticity and functional recovery in multiple sclerosis.

  Journal article

  Tomassini V. et al, (2012), Nat Rev Neurol, 8, 635 - 646

• FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES

  Conference paper

  Finlayson S. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83, A23 - A23

• NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT

  Conference paper

  George J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND

  Conference paper

  Luppe S. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE

  Conference paper

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES

  Conference paper

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• Neuroplasticity and functional recovery in multiple sclerosis

  Journal article

  Tomassini V. et al, (2012), Nature Reviews Neurology, 8, 635 - 646

• Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica

  Conference paper

  Sedani S. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 296 - 297

• The association between sunlight hours and month of birth in multiple sclerosis patients across UK regions

  Conference paper

  Matthews LAE. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 375 - 376

• Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort

  Conference paper

  Leonard HAC. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 291 - 292

• Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics

  Conference paper

  Matthews LAE. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 9 - 10

• The differential diagnoses of patients presenting with longitudinally extensive transverse myelitis: analysis of 76 cases

  Conference paper

  Kitley J. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 68 - 68

• Seasonal pattern of variation in neuromyelitis optica relapses

  Conference paper

  Elsone L. et al, (2012), MULTIPLE SCLEROSIS JOURNAL, 18, 292 - 292

• A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

  Journal article

  Kolasinski J. et al, (2012), Brain, 135, 2938 - 2951

• Treatment of neuromyelitis optica: Review and recommendations

  Journal article

  Kimbrough DJ. et al, (2012), Multiple Sclerosis and Related Disorders, 1, 180 - 187

• Treatment of Neuromyelitis Optica: Review and Recommendations.

  Journal article

  Kimbrough DJ. et al, (2012), Mult Scler Relat Disord, 1, 180 - 187

• Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.

  Journal article

  Kitley J. et al, (2012), Neurology, 79, 1273 - 1277

• Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.

  Journal article

  Pitceathly RD. et al, (2012), Neurology, 79, 1145 - 1154

• Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol

  Conference paper

  Gibbons CJ. et al, (2012), EUROPEAN JOURNAL OF NEUROLOGY, 19, 264 - 264

• Therapy of myasthenic syndrome

  Conference paper

  Palace J., (2012), EUROPEAN JOURNAL OF NEUROLOGY, 19, 824 - 824

• A practical guide to the treatment of neuromyelitis optica.

  Journal article

  Palace J. et al, (2012), Pract Neurol, 12, 209 - 214

• Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis.

  Journal article

  Popescu V. et al, (2012), Neuroimage, 61, 1484 - 1494

• Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.

  Journal article

  Belaya K. et al, (2012), Am J Hum Genet, 91, 193 - 201

• Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates

  Journal article

  Belaya K. et al, (2012), American Journal of Human Genetics, 91, 193 - 201

• Relating brain damage to brain plasticity in patients with multiple sclerosis.

  Journal article

  Tomassini V. et al, (2012), Neurorehabil Neural Repair, 26, 581 - 593

• Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects

  Journal article

  Bibani RH. et al, (2012), Multiple Sclerosis and Related Disorders, 1, 131 - 135

• The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?

  Journal article

  Taghipour K. et al, (2012), J Am Acad Dermatol, 67, 160 - 161

• Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects.

  Journal article

  Bibani RH. et al, (2012), Mult Scler Relat Disord, 1, 131 - 135

• Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.

  Journal article

  Kitley J. et al, (2012), Brain, 135, 1834 - 1849

• Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multicentre FIRST study

  Conference paper

  Kappos L. et al, (2012), JOURNAL OF NEUROLOGY, 259, S64 - S65

• Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients

  Conference paper

  Gold R. et al, (2012), JOURNAL OF NEUROLOGY, 259, S69 - S69

• Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.

  Journal article

  Leite MI. et al, (2012), Neurology, 78, 1601 - 1607

• Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.

  Journal article

  Guergueltcheva V. et al, (2012), J Neurol, 259, 838 - 850

• Influence of pregnancy on neuromyelitis optica spectrum disorder.

  Journal article

  Kim W. et al, (2012), Neurology, 78, 1264 - 1267

• Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?

  Journal article

  Downer JJ. et al, (2012), Neuroradiology, 54, 279 - 285

• Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?

  Journal article

  Downer JJ. et al, (2012), Neuroradiology, 54, 279 - 285

• Cardiac Safety of Fingolimod 0.5 mg during the First Dose Observation in 4-Month, Open-Label, Multi-Center FIRST Study in Patients with Relapsing MS

  Conference paper

  Comi G. et al, (2012), NEUROLOGY, 78

• AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  Conference paper

  Arun T. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME

  Conference paper

  Chaouch A. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment

  Conference paper

  Beeson D. et al, (2012), NEUROMUSCULAR DISORDERS, 22, S16 - S16

• Myelin water imaging reflects clinical variability in multiple sclerosis.

  Journal article

  Kolind S. et al, (2012), Neuroimage, 60, 263 - 270

• Myelin water imaging reflects clinical variability in multiple sclerosis

  Journal article

  Kolind S. et al, (2012), NeuroImage, 60, 263 - 270

• CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?

  Conference paper

  Matthews L. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• COMPARISON OF HISTOLOGICAL AND DIFFUSION-WEIGHTED MRI TECHNIQUES IN THE ANALYSIS OF POST MORTEM MULTIPLE SCLEROSIS BRAINS

  Conference paper

  Kolasinski J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• The differential diagnosis of longitudinally extensive transverse myelitis.

  Journal article

  Kitley JL. et al, (2012), Mult Scler, 18, 271 - 285

• TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE

  Conference paper

  Elsone L. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER

  Conference paper

  Leite MI. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS

  Conference paper

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK

  Conference paper

  Kitley J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• AQUAPORIN 4 ANTIBODY SEROPOSITIVITY AND VISUAL FUNCTION IN A UK COHORT

  Conference paper

  George J. et al, (2012), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83

• Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

  Journal article

  Waters PJ. et al, (2012), Neurology, 78, 665 - 671

• Clinical features in a series of fast channel congenital myasthenia syndrome.

  Journal article

  Palace J. et al, (2012), Neuromuscul Disord, 22, 112 - 117

• Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

  Journal article

  Kitley J. et al, (2012), Brain, 135, 1834 - 1849

• Prognostic factors in aquaporin-4 antibody-mediated disease: UK and Japanese cohorts

  Journal article

  Kitley J. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S291 - S291

• Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica

  Journal article

  Kitley J. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S281 - S281

• Distinction of aquaporin-4 antibody positive neuromyelitis optica from multiple sclerosis using diffusion tensor and myelin water imaging

  Journal article

  Matthews L. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S165 - S165

• Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort

  Journal article

  Wakerley BR. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S296 - S297

• Aquaporin 4 antibody seropositivity and visual function in a UK cohort

  Journal article

  George J. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S493 - S494

• Acid-sensing ion channel 1 blockade preserves brain microstructural integrity in patients with multiple sclerosis

  Journal article

  de Ruiter MB. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S205 - S205

• Autoimmunity to astrocytes in multiple sclerosis and EAE

  Journal article

  Amor S. et al, (2011), MULTIPLE SCLEROSIS JOURNAL, 17, S122 - S122

• Use of mitoxantrone in neuromyelitis optica.

  Journal article

  Kitley JL. et al, (2011), Arch Neurol, 68

• Acute disseminated encephalomyelitis and its place amongst other acute inflammatory demyelinating CNS disorders.

  Journal article

  Palace J., (2011), J Neurol Sci, 306, 188 - 191

• MRI assessment of iron deposition in multiple sclerosis.

  Journal article

  Ropele S. et al, (2011), J Magn Reson Imaging, 34, 13 - 21

• The diagnostic conundrum of primary angiitis of the central nervous system: a case report.

  Journal article

  Gill D. et al, (2011), J Neurol, 258, 925 - 928

• Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.

  Journal article

  Senderek J. et al, (2011), Am J Hum Genet, 88, 162 - 172

• Authors' reply to BioMarin Europe

  Journal article

  Nicholl DJ. et al, (2011), BMJ, 342

• Orphan drugs Authors' reply to BioMarin Europe

  Journal article

  Nicholl DJ. et al, (2011), BRITISH MEDICAL JOURNAL, 342

• Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations

  Journal article

  Guergueltcheva V. et al, (2011), Journal of Neurology, 1 - 13

• Clinical features in a series of fast channel congenital myasthenia syndrome

  Journal article

  Palace J. et al, (2011), Neuromuscular Disorders

• Preservation of motor skill learning in patients with multiple sclerosis.

  Journal article

  Tomassini V. et al, (2011), Mult Scler, 17, 103 - 115

• Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.

  Journal article

  Munot P. et al, (2010), Neuromuscul Disord, 20, 796 - 800

• Orphan Drugs Open letter to prime minister David Cameron and health secretary Andrew Lansley

  Journal article

  Nicholl DJ. et al, (2010), BRITISH MEDICAL JOURNAL, 341

• Open letter to prime minister David Cameron and health secretary Andrew Lansley.

  Journal article

  Nicholl DJ. et al, (2010), BMJ, 341

• PREDICTING BRAIN ATROPHY AT 1 YEAR BY BASELINE MULTIMODAL MRI DATA

  Conference paper

  Tarunya A. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E42 - E42

• DIRECT COMPARISON OF MULTIPLE NONLESIONAL IMAGING MEASURES TO ASSESS THEIR POWER TO MEASURE TREATMENT EFFECTS OVER 1 YEAR IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  Conference paper

  Arun T. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E52 - E53

• "THE EYES HAVE IT": INITIAL GENETIC SCREENING IN SUSPECTED CONGENITAL MYASTHENIA

  Conference paper

  Lashley D. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E63 - E63

• COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  Conference paper

  Matthews L. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E56 - E56

• AQUAPORIN-4 M 23 ISOFORM PROVIDES A MORE SENSITIVE ASSAY FOR AQUAPORIN-4 ANTIBODIES

  Conference paper

  Waters P. et al, (2010), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81, E32 - E32

• Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis

  Journal article

  Sørensen PS. et al, (2010), 1, 63 - 74

• Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.

  Journal article

  Stagg CJ. et al, (2010), Epilepsia, 51, 1898 - 1901

• Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes

  Conference paper

  Palace J., (2010), EUROPEAN JOURNAL OF NEUROLOGY, 17, 628 - 628

• Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.

  Journal article

  Palace J. et al, (2010), Arch Neurol, 67, 1016 - 1017

• Clinical aspects of myasthenia explained.

  Journal article

  Verschuuren JJ. et al, (2010), Autoimmunity, 43, 344 - 352

• Intercenter differences in diffusion tensor MRI acquisition.

  Journal article

  Pagani E. et al, (2010), J Magn Reson Imaging, 31, 1458 - 1468

• Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.

  Journal article

  Lashley D. et al, (2010), Neurology, 74, 1517 - 1523

• Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

  Conference paper

  Cossins J. et al, (2010), NEUROMUSCULAR DISORDERS, 20, S18 - S18

• MRI criteria for MS in patients with clinically isolated syndromes.

  Journal article

  Montalban X. et al, (2010), Neurology, 74, 427 - 434

• Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.

  Journal article

  Giorgio A. et al, (2010), J Magn Reson Imaging, 31, 309 - 316

• Modafinil for multiple sclerosis fatigue: does it work?

  Journal article

  Littleton ET. et al, (2010), Clin Neurol Neurosurg, 112, 29 - 31

• Open letter to prime minister David Cameron and health secretary Andrew Lansley.

  Journal article

  Nicholl DJ. et al, (2010), BMJ (Clinical research ed.), 341

• Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

  Journal article

  Boggild M. et al, (2009), BMJ, 339

• The borderland of neuromyelitis optica.

  Journal article

  Matthews LA. et al, (2009), Pract Neurol, 9, 335 - 340

• Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.

  Journal article

  Palace J., (2009), J Neurol Sci, 286, 24 - 27

• EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA

  Conference paper

  Lashley D. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME

  Conference paper

  Lashley D. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• MOTOR SKILL LEARNING IN MULTIPLE SCLEROSIS

  Conference paper

  Tomassini V. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• THE THALAMUS AND NEUROPATHIC PAIN IN MULTIPLE SCLEROSIS

  Conference paper

  Seixas D. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• SERUM ANTIBODIES IN EPILEPSY

  Conference paper

  Brenner T. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• SERUM ANTIBODIES IN EPILEPSY

  Conference paper

  Brenner T. et al, (2009), EPILEPSIA, 50, 484 - 485

• SEX RATIO IN AN OXFORD BASED STUDY OF MULTIPLE SCLEROSIS PATIENTS

  Conference paper

  Matthews L. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT

  Conference paper

  Leite MI. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY

  Conference paper

  Jacob A. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• LATE ADULT ONSET TEMPORAL LOBE EPILEPSY WITH ANTIBODIES TO VOLTAGE GATED POTASSIUM CHANNELS

  Conference paper

  Matthews L. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80

• Functional correlates of motor learning in multiple sclerosis

  Journal article

  Tomassini V. et al, (2009), MULTIPLE SCLEROSIS, 15, S96 - S96

• MS patients with chronic pain have more myelin water and less heterogeneous T1 values in normal-appearing white matter than matched MS patients without pain

  Journal article

  Kolind S. et al, (2009), MULTIPLE SCLEROSIS, 15, S209 - S209

• The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis

  Journal article

  Clerico M. et al, (2009), MULTIPLE SCLEROSIS, 15, S137 - S138

• PLS models discriminate types of MS from spectroscopic analysis of plasma and urinele

  Conference paper

  Dickens AM. et al, (2009), MULTIPLE SCLEROSIS, 15, S275 - S275

• Multiple sclerosis lesions: insights from imaging techniques.

  Journal article

  Tomassini V. and Palace J., (2009), Expert Rev Neurother, 9, 1341 - 1359

• Functional connectivity changes of the motor network in patients with multiple sclerosis: a multicentre fMRI study

  Conference paper

  Rocca M. et al, (2009), MULTIPLE SCLEROSIS, 15, S99 - S99

• Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.

  Journal article

  Cader S. et al, (2009), J Psychopharmacol, 23, 686 - 696

• Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.

  Journal article

  Rocca MA. et al, (2009), Hum Brain Mapp, 30, 2412 - 2425

• Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.

  Journal article

  Littleton E. et al, (2009), Mol Cell Proteomics, 8, 1688 - 1696

• Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.

  Journal article

  Viegas S. et al, (2009), J Neurol Neurosurg Psychiatry, 80, 679 - 682

• To differentiate the indication to treat the clinically isolated syndrome on the bases of different clinical onsets. The subgroup analyses from a Cochrane meta-analysis

  Journal article

  Clerico M. et al, (2009), JOURNAL OF NEUROLOGY, 256, S11 - S11

• Functional connectivity changes of the motor network in patients with multiple sclerosis: a multi-centre fMRI study

  Conference paper

  Filippi M. et al, (2009), JOURNAL OF NEUROLOGY, 256, S47 - S48

• T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides (DOI:10.1016/j.immuni.2009.01.009)

  Journal article

  Harkiolaki M. et al, (2009), Immunity, 30

• Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis.

  Journal article

  Mancini L. et al, (2009), Neuroimage, 45, 500 - 511

• BEFORE AND AFTER THE ACUTE MS LESION: A LONGITUDINAL DTI STUDY

  Conference paper

  Giorgio A. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80, 463 - 463

• SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY

  Journal article

  Stagg CJ. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80, 463 - 463

• THE OXFORD EXPERIENCE OF THYMOMA SURGERY IN PATIENTS WITH MG: 1998-2007

  Journal article

  Viegas S. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80, 452 - 452

• OUTPATIENT TARGETS: TOWARDS A FASTER TRACK SYSTEM

  Journal article

  Bosnell RA. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80, 457 - 457

• EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

  Journal article

  Arun T. et al, (2009), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 80, 463 - 463

• Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?

  Journal article

  Korteweg T. et al, (2009), Mult Scler, 15, 465 - 471

• T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.

  Journal article

  Harkiolaki M. et al, (2009), Immunity, 30, 348 - 357

• Guidelines for differential diagnosis of suspected multiple sclerosis.

  Journal article

  Palace J., (2009), Nat Clin Pract Neurol, 5, 134 - 135

• The multiple sclerosis risk sharing scheme monitoring study - Early results and lessons for the future

  Journal article

  Pickin M. et al, (2009), BMC Neurology, 9

• The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the future.

  Journal article

  Pickin M. et al, (2009), BMC Neurol, 9

• The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells

  Conference paper

  Spearman H. et al, (2008), NEUROMUSCULAR DISORDERS, 18, 748 - 748

• The congenital myasthenic syndromes.

  Journal article

  Palace J. and Beeson D., (2008), J Neuroimmunol, 201-202, 2 - 5

• Congenital myasthenic syndromes in childhood: diagnostic and management challenges.

  Journal article

  Kinali M. et al, (2008), J Neuroimmunol, 201-202, 6 - 12

• The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis

  Conference paper

  Palace J. et al, (2008), MULTIPLE SCLEROSIS, 14, S171 - S171

• Optimizing diffusion measurements for large-scale, multicenter multiple sclerosis trials: a pan-European study

  Conference paper

  Rovaris M. et al, (2008), MULTIPLE SCLEROSIS, 14, S216 - S216

• Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis

  Conference paper

  Clerico M. et al, (2008), MULTIPLE SCLEROSIS, 14, S61 - S61

• Reproducibility of fMRI in the clinical setting: implications for trial designs.

  Journal article

  Bosnell R. et al, (2008), Neuroimage, 42, 603 - 610

• Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

  Journal article

  Waters P. et al, (2008), Arch Neurol, 65, 913 - 919

• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

  Journal article

  Clerico M. et al, (2008), Cochrane database of systematic reviews (Online)

• Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis

  Conference paper

  Clerico M. et al, (2008), JOURNAL OF NEUROLOGY, 255, 37 - 37

• Optimising diffusion measurements for large-scale, multicentre multiple sclerosis trials: a pan-European study

  Conference paper

  Perego E. et al, (2008), JOURNAL OF NEUROLOGY, 255, 84 - 84

• Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition.

  Journal article

  Manson SC. et al, (2008), Exp Brain Res, 187, 25 - 31

• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

  Journal article

  Clerico M. et al, (2008), Cochrane Database Syst Rev

• The evolving clinical spectrum of neuromyelitis optica

  Conference paper

  Viegas SD. et al, (2008), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 79, 344 - 344

• Neuroprotection and repair.

  Journal article

  Palace J., (2008), J Neurol Sci, 265, 21 - 25

• Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.

  Journal article

  Wegner C. et al, (2008), Eur J Neurol, 15, 113 - 122

• Congenital myasthenic syndromes and the formation of the neuromuscular junction.

  Conference paper

  Beeson D. et al, (2008), Ann N Y Acad Sci, 1132, 99 - 103

• Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

  Journal article

  Tzartos JS. et al, (2008), Am J Pathol, 172, 146 - 155

• MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

  Journal article

  Seewann A. et al, (2008), J Neurol, 255, 1 - 10

• Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.

  Journal article

  Blamire AM. et al, (2007), Magn Reson Med, 58, 880 - 885

• Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing

  Conference paper

  Jarius S. et al, (2007), MULTIPLE SCLEROSIS, 13, S158 - S158

• Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis

  Conference paper

  Jarius S. et al, (2007), MULTIPLE SCLEROSIS JOURNAL, 13, S159 - S159

• Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials

  Conference paper

  Clerico M. et al, (2007), MULTIPLE SCLEROSIS, 13, S92 - S92

• Prevalence and geographical distribution of UK congenital myasthenic syndrome patients referred to the oxford national specialist commissioning advisory group service

  Conference paper

  Lashley D. et al, (2007), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78, 1020 - 1020

• A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)

  Conference paper

  Waters P. et al, (2007), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78, 1030 - 1030

• Diffusion tensor imaging defines subregions of human lateral premotor cortex with distinct frontoparietal connections

  Conference paper

  Tomassini V. et al, (2007), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78, 1028 - 1028

• Transcranial direct current stimulation: A potential tool for rehabilitation?

  Conference paper

  Stagg CJ. et al, (2007), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78, 1036 - 1036

• Inflammation versus neurodegeneration: consequences for treatment.

  Journal article

  Palace J., (2007), J Neurol Sci, 259, 46 - 49

• Clinical features of the DOK7 neuromuscular junction synaptopathy.

  Journal article

  Palace J. et al, (2007), Brain, 130, 1507 - 1515

• Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.

  Journal article

  Cader S. et al, (2007), Neuroimage, 36, 19 - 27

• White matter changes in Leber's hereditary optic neuropathy: MRI findings.

  Journal article

  Küker W. et al, (2007), Eur J Neurol, 14, 591 - 593

• Immunomodulatory treatments for preventing conversion from clinically isolated syndromes to multiple sclerosis: a Cochrane review on their efficacy

  Conference paper

  Clerico M. et al, (2007), JOURNAL OF NEUROLOGY, 254, 165 - 165

• Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

  Journal article

  Paul F. et al, (2007), PLoS Med, 4

• NMO-IgG in the diagnosis of neuromyelitis optica.

  Journal article

  Jarius S. et al, (2007), Neurology, 68, 1076 - 1077

• Towards defining antigenic targets for antibodies in multiple sclerosis

  Conference paper

  Littleton ET. et al, (2006), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 77, 1399 - 1400

• Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.

  Conference paper

  Beeson D. et al, (2006), ANNALS OF NEUROLOGY, 60, 640 - 640

• Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations

  Journal article

  Cossins J. et al, (2006), Brain, 129, 2773 - 2783

• Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.

  Journal article

  Cossins J. et al, (2006), Brain, 129, 2773 - 2783

• Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy.

  Journal article

  Manson SC. et al, (2006), Exp Brain Res, 174, 728 - 733

• Dok-7 mutations underlie a neuromuscular junction synaptopathy.

  Journal article

  Beeson D. et al, (2006), Science, 313, 1975 - 1978

• Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

  Journal article

  Wegner C. et al, (2006), Neurology, 67, 960 - 967

• Running a mitoxantrone service for multiple sclerosis

  Conference paper

  Craner MI. et al, (2006), MULTIPLE SCLEROSIS, 12, S211 - S211

• Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis

  Conference paper

  Clerico M. et al, (2006), MULTIPLE SCLEROSIS, 12, S128 - S128

• MRI in Leber's optic neuropathy with multiple sclerosis (Harding's disease)

  Conference paper

  Kuker W. et al, (2006), MULTIPLE SCLEROSIS, 12, S165 - S165

• Interleukin-17 expression in multiple sclerosis

  Conference paper

  Tzartos JS. et al, (2006), JOURNAL OF NEUROIMMUNOLOGY, 178, 201 - 201

• An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica

  Conference paper

  Littleton ET. et al, (2006), MULTIPLE SCLEROSIS, 12, S156 - S156

• APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.

  Journal article

  Burwick RM. et al, (2006), Neurology, 66, 1373 - 1383

• A Cochrane review on immunomodulatory treatments in clinically isolated syndromes at risk of converting to multiple sclerosis

  Conference paper

  Clerico M. et al, (2006), JOURNAL OF NEUROLOGY, 253, 127 - 127

• Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis.

  Journal article

  Cader S. et al, (2006), Brain, 129, 527 - 537

• A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes

  Journal article

  Burke G. et al, (2006), DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 48, 5 - 5

• Effect of sildenafil citrate (Viagra) on cerebral blood flow in patients with multiple sclerosis

  Conference paper

  Burke G. et al, (2006), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 77, 130 - 130

• Serum antibodies in epilepsy and seizure-associated disorders.

  Journal article

  McKnight K. et al, (2005), Neurology, 65, 1730 - 1736

• Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis.

  Journal article

  Sørensen PS. et al, (2005), Eur J Neurol, 12, 817 - 827

• The genetic diagnosis of congenital myasthenic syndromes (CMS)

  Conference paper

  Man S. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 1324 - 1325

• Viral vectors for immunisation against potassium channel Kv1.2

  Conference paper

  McKnight KM. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 1321 - 1321

• Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

  Conference paper

  Clerico M. et al, (2005), MULTIPLE SCLEROSIS, 11, S111 - S112

• The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis

  Conference paper

  Burke G. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 1326 - 1326

• Neuropathological features of multiple sclerosis (MS) can be seen in a humanised mouse model of EAE with heterogeneous clinical aspects

  Conference paper

  Tzartos JS. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 1320 - 1320

• Effect of sildenafil citrate on CBF and BOLD activation in multiple sclerosis patients

  Conference paper

  Manson SC. et al, (2005), MULTIPLE SCLEROSIS, 11, S59 - S59

• An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

  Conference paper

  Littleton ET. and Palace J., (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 1316 - 1316

• A case of MS, ADEM, NMO or all three?

  Conference paper

  Pomeroy IM. et al, (2005), MULTIPLE SCLEROSIS, 11, S20 - S20

• MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).

  Journal article

  Fazekas F. et al, (2005), Mult Scler, 11, 433 - 440

• Sjogren's myelopathy

  Conference paper

  Mukhtyar C. et al, (2005), RHEUMATOLOGY, 44, I120 - I121

• The management of myasthenia gravis

  Journal article

  Hilton-Jones D. and Palace J., (2005), Practical Neurology, 5, 18 - 27

• Serum antibodies in patients with epilepsy

  Conference paper

  Lang B. et al, (2005), EPILEPSIA, 46, 76 - 76

• Typical cortical lesions in an animal model of MS

  Conference paper

  Pomeroy IM. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 152 - 152

• Synaptic loss and impaired synaptic plasticity in cortical lesions of multiple sclerosis

  Conference paper

  Wegner C. et al, (2005), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 76, 152 - 152

• Myasthenia gravis and Lambert-Eaton myasthenic syndrome

  Journal article

  Palace J. and Hilton-Jones D., (2004), Medicine, 32, 114 - 118

• Reduced growth associated protein-43 and synaptic loss in cortical lesions of multiple sclerosis

  Conference paper

  Wegner C. et al, (2004), MULTIPLE SCLEROSIS, 10, S155 - S155

• Patient choice and adherence with disease-modifying therapy in multiple sclerosis

  Conference paper

  Burke G. et al, (2004), MULTIPLE SCLEROSIS, 10, S189 - S189

• An approach to the identification of targets of autoantibodies in multiple sclerosis

  Conference paper

  Littleton ET. et al, (2004), JOURNAL OF NEUROIMMUNOLOGY, 154, 91 - 91

• A verbal working memory task reveals new differences in the activation pattern of multiple sclerosis patients compared with healthy controls

  Conference paper

  Cader MZ. et al, (2004), MULTIPLE SCLEROSIS, 10, S102 - S103

• The multiple sclerosis monitoring study: Progress to date

  Conference paper

  Cooper C. et al, (2004), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 75, 1214 - 1214

• Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.

  Journal article

  Watson R. et al, (2004), Neurology, 63, 43 - 50

• Distinct phenotypes of congenital acetylcholine receptor deficiency.

  Journal article

  Burke G. et al, (2004), Neuromuscul Disord, 14, 356 - 364

• The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?

  Journal article

  Maggs FG. and Palace J., (2004), Mult Scler, 10, 326 - 329

• Synaptic loss and impaired synaptic plasticity in cortical lesions of multiple sclerosis

  Conference paper

  Wegner C. et al, (2004), JOURNAL OF NEUROLOGY, 251, 24 - 24

• Potassium channel antibody associated encephalitis: A potentially treatable non-paraneoplastic limbic encephalitis

  Conference paper

  Schott JM. et al, (2004), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 75, 519 - 519

• The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease

  Conference paper

  Seymour A. et al, (2004), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 75, 518 - 518

• Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

  Journal article

  Vincent A. et al, (2004), Brain, 127, 701 - 712

• Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis

  Journal article

  Vincent A. et al, (2004), Brain, 127, 701 - 712

• Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.

  Journal article

  Lily O. et al, (2004), Brain, 127, 269 - 279

• Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine.

  Journal article

  Parry AM. et al, (2003), Brain, 126, 2750 - 2760

• The measurement of antibodies binding to IFNβ in MS patients treated with IFNβ

  Journal article

  Pachner AR. et al, (2003), Neurology, 61

• The measurement of antibodies binding to IFNbeta in MS patients treated with IFNbeta.

  Journal article

  Pachner AR. et al, (2003), Neurology, 61, S18 - S20

• The measurement of antibodies binding to IFN beta in MS patients treated with IFN beta

  Conference paper

  Pachner AR. et al, (2003), NEUROLOGY, 61, S18 - S20

• Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

  Journal article

  Burke G. et al, (2003), Neurology, 61, 826 - 828

• A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN beta.

  Journal article

  Lawrence N. et al, (2003), J Neurol Neurosurg Psychiatry, 74, 1236 - 1239

• T1 changes detect the progression of pathology in the white matter and cortex of MS patients

  Conference paper

  Palace J. et al, (2003), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 1179 - 1179

• Congenital myasthenia - Rapsyn deficiency: How rare?

  Conference paper

  Burke G. et al, (2003), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 1181 - 1181

• Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis

  Conference paper

  Cifelli AI. et al, (2003), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 1177 - 1177

• Autoantibodies as a cause of epilepsy

  Conference paper

  Wroe S. et al, (2003), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 1181 - 1181

• MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex.

  Journal article

  Parry A. et al, (2003), J Neuroimaging, 13, 234 - 239

• Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

  Journal article

  Wylezinska M. et al, (2003), Neurology, 60, 1949 - 1954

• Antibodies to neuronal targets in neurological and psychiatric diseases.

  Journal article

  Vincent A. et al, (2003), Ann N Y Acad Sci, 992, 48 - 55

• The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis

  Conference paper

  Dalton C. et al, (2003), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 399 - 399

• Clinical and laboratory characteristics of secondary progressive MS.

  Journal article

  Palace J., (2003), J Neurol Sci, 206, 131 - 134

• Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.

  Journal article

  Parry A. et al, (2003), J Neurol, 250, 171 - 178

• Thalamic neurodegeneration in multiple sclerosis.

  Journal article

  Cifelli A. et al, (2002), Ann Neurol, 52, 650 - 653

• White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.

  Journal article

  Parry A. et al, (2002), J Neurol, 249, 1279 - 1286

• Serum autoantibodies against intracellular antigens in multiple sclerosis

  Journal article

  Lily O. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73, 227 - 227

• Antibodies to voltage gated potassium channels in encephalitis

  Journal article

  Palace J. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73, 234 - 234

• The UK MS database

  Journal article

  Palace J. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73, 228 - 228

• Grey matter neuronal loss in multiple sclerosis

  Journal article

  Cifelli A. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73, 226 - 226

• beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis

  Journal article

  Parry A. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73, 214 - 214

• An unusual case of forearm hyperhidrosis

  Journal article

  Reddel S. et al, (2002), NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 365, R36 - R36

• Intravenous immunoglobulin in neurological disease: a specialist review.

  Journal article

  Wiles CM. et al, (2002), J Neurol Neurosurg Psychiatry, 72, 440 - 448

• Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients

  Journal article

  Lily O. et al, (2002), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 72, 137 - 137

• Making the diagnosis of multiple sclerosis.

  Journal article

  Palace J., (2001), J Neurol Neurosurg Psychiatry, 71 Suppl 2, ii3 - ii8

• Myasthenia gravis: diagnostic and management dilemmas.

  Journal article

  Palace J. et al, (2001), Curr Opin Neurol, 14, 583 - 589

• Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis.

  Journal article

  Evangelou N. et al, (2001), Brain, 124, 1813 - 1820

• Myasthenia gravis.

  Journal article

  Vincent A. et al, (2001), Lancet, 357, 2122 - 2128

• PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

  Journal article

  Francis G. et al, (2001), NEUROLOGY, 56, 1628 - 1636

• Randomized controlled trial of interferon-beta-1a in secondary progressive MS - Clinical results

  Journal article

  King J. et al, (2001), NEUROLOGY, 56, 1496 - 1504

• Functional dissection of the anterior cingulate cortex using behavioural correlates with fMRI in the counting stroop.

  Journal article

  Parry A. et al, (2001), NEUROIMAGE, 13, S343 - S343

• Epilepsy: an autoimmune disease?

  Journal article

  Palace J. and Lang B., (2000), J Neurol Neurosurg Psychiatry, 69, 711 - 714

• Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.

  Journal article

  Evangelou N. et al, (2000), Brain, 123 ( Pt 9), 1845 - 1849

• Axonal loss in the optic nerve and tract in multiple sclerosis

  Conference paper

  Esiri M. et al, (2000), BRAIN PATHOLOGY, 10, 643 - 643

• The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis.

  Journal article

  Lee M. et al, (2000), Ann Neurol, 47, 606 - 613

• Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.

  Journal article

  Evangelou N. et al, (2000), Ann Neurol, 47, 391 - 395

• Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.

  Journal article

  Lee MA. et al, (2000), Arch Neurol, 57, 65 - 70

• Pathogenic autoantibodies to neuronal proteins in neurological disorders.

  Journal article

  Vincent A. et al, (1999), J Neuroimmunol, 100, 169 - 180

• Application of lesion probability maps to analysis of the spatio-temporal evolution of the T2-hyperintense lesions of multiple sclerosis (MS)

  Conference paper

  Lee MA. et al, (1999), NeuroImage, 9

• The effect of anti-α4 integrin antibody on brain lesion activity in MS

  Journal article

  Tubridy N. et al, (1999), Neurology, 53, 466 - 472

• The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

  Journal article

  Tubridy N. et al, (1999), Neurology, 53, 466 - 472

• The UK Multiple Sclerosis database.

  Journal article

  Palace J. and Boggild M., (1999), Mult Scler, 5, 297 - 298

• Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.

  Journal article

  Evangelou N. et al, (1999), J Neurol Neurosurg Psychiatry, 67, 203 - 205

• Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: Evidence for distinct mechanisms of lesion genesis?

  Journal article

  Lee MA. et al, (1999), Brain, 122, 1261 - 1270

• Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?

  Journal article

  Lee MA. et al, (1999), Brain, 122 ( Pt 7), 1261 - 1270

• Dissociation of 'on-line' and 'off-line' visuomotor control of the arm by focal lesions in the cerebellum and brainstem.

  Journal article

  Liu X. et al, (1999), Neurosci Lett, 264, 121 - 124

• Changes in motor evoked potentials to short-interval paired transcranial magnetic stimuli in multiple sclerosis.

  Journal article

  Ho KH. et al, (1999), Clin Neurophysiol, 110, 712 - 719

• Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

  Journal article

  Lee MA. et al, (1999), Brain, 122 ( Pt 2), 191 - 197

• Distal versus proximal arm tremor in multiple sclerosis assessed by visually guided tracking tasks.

  Journal article

  Liu X. et al, (1999), J Neurol Neurosurg Psychiatry, 66, 43 - 47

• Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

  Journal article

  (1998), Lancet, 352, 1498 - 1504

• Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.

  Journal article

  Lee MA. et al, (1998), Brain, 121 ( Pt 11), 2095 - 2102

• A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis

  Journal article

  Palace J. et al, (1998), Neurology, 50, 1778 - 1783

• A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

  Journal article

  Palace J. et al, (1998), Neurology, 50, 1778 - 1783

• A radioimmuno-precipitation assay for antibodies to botulinum A.

  Journal article

  Palace J. et al, (1998), Neurology, 50, 1463 - 1466

• New and old treatments for multiple sclerosis.

  Journal article

  Palace J., (1998), Neurologia, 13, 162 - 165

• Distal versus proximal arm tremor in multiple sclerosis assessed by visually guided tracking tasks.

  Journal article

  Liu X. et al, (1998), EUROPEAN JOURNAL OF NEUROSCIENCE, 10, 191 - 191

• Analysis of action tremor and impaired control of movement velocity in multiple sclerosis during visually guided wrist-tracking tasks.

  Journal article

  Liu X. et al, (1997), Mov Disord, 12, 992 - 999

• Value of sphincter electromyography in the diagnosis of multiple system atrophy.

  Journal article

  Palace J. et al, (1997), Muscle Nerve, 20, 1396 - 1403

• Congenital myasthenic syndromes.

  Journal article

  Beeson D. et al, (1997), Curr Opin Neurol, 10, 402 - 407

• New treatments and azathioprine in multiple sclerosis.

  Journal article

  Palace J. and Rothwell P., (1997), Lancet, 350

• How to recognize patients with parkinsonism who should not have urological surgery.

  Journal article

  Chandiramani VA. et al, (1997), Br J Urol, 80, 100 - 104

• Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

  Journal article

  Motomura M. et al, (1997), J Neurol Sci, 147, 35 - 42

• Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.

  Journal article

  Glennerster A. et al, (1996), Neurology, 46, 1138 - 1142

• Guillain-Barré syndrome with severe persistent disability: relationship to hyperacute Guillain-Barré syndrome.

  Journal article

  Palace JA. and Hughes RA., (1994), Eur J Neurol, 1, 21 - 27

• Immunogenicity of human recombinant acetylcholine receptor alpha subunit: cytoplasmic epitopes dominate the antibody response in four mouse strains.

  Journal article

  Palace J. et al, (1994), Autoimmunity, 18, 113 - 119

• Primary CNS lymphoma.

  Journal article

  Losseff N. and Palace J., (1993), Br J Hosp Med, 50, 678 - 679

• Clinical and experimental observations in patients with congenital myasthenic syndromes.

  Journal article

  Vincent A. et al, (1993), Ann N Y Acad Sci, 681, 451 - 460

• Isolated dysphagia due to polymyositis.

  Journal article

  Palace J. et al, (1993), Muscle Nerve, 16, 680 - 681

• Letters to the editor

  Journal article

  Singer C. et al, (1993), Muscle & Nerve, 16, 677 - 682

• CLINICAL AND EXPERIMENTAL-OBSERVATIONS IN PATIENTS WITH CONGENITAL MYASTHENIC SYNDROMES

  Conference paper

  VINCENT A. et al, (1993), MYASTHENIA GRAVIS AND RELATED DISORDERS : EXPERIMENTAL AND CLINICAL ASPECTS, 681, 451 - 460

• Flecainide induced peripheral neuropathy.

  Journal article

  Palace J. et al, (1992), BMJ, 305

• Stroke following marijuana smoking.

  Journal article

  Barnes D. et al, (1992), Stroke, 23

• Stroke following marijuana smoking

  Journal article

  Barn Es D. et al, (1992), Stroke, 23

• 3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

  Journal article

  Palace J. et al, (1991), J Neurol Neurosurg Psychiatry, 54, 1069 - 1072

• Cryptococcal choroidoretinitis and immunodeficiency.

  Journal article

  Church WH. et al, (1987), Postgrad Med J, 63, 969 - 971

• Disorders of the neuromuscular junction

  Chapter

  Hilton-Jones, David None. and Palace J., Oxford Textbook of Medicine

• Clinical presentation and prognosis in MOG-antibody disease, analysis of 252 patients from the United Kingdom

  Journal article

  Jurynczyk M. et al, Brain

• Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.

  Journal article

  Chaouch A. et al, J Neuromuscul Dis, 1, 75 - 90

Recent Publications

• Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.

  Journal article

  Sisay S. et al, (2017), J Neuroimmunol, 306, 40 - 45

• Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.

  Journal article

  Jurynczyk M. et al, (2017), Brain, 140, 617 - 627

• Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

  Journal article

  Juryńczyk M. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 132 - 136

• Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

  Journal article

  Tackley G. et al, (2017), J Neurol Neurosurg Psychiatry, 88, 165 - 169

• Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

  Journal article

  Geraldes R. et al, (2016), Brain Pathol